Magnetic brain stimulation on the left or right side in fibromyalgia
Tests how rTMS changes brain activity on each side in people with fibromyalgia.
Key facts
- Who runs it
- University of Rochester
- Where
- Rochester, United StatesSee the site
- Trial code
- Registry title
- Investigating the Effects of Repetitive Transcranial Magnetic Stimulation (rTMS) on the Brain in People With Fibromyalgia
- Status
- Recruiting
- People taking part
- 20 people, planned
- Started
- 5 Dec 2025
- Expected to end
- Jan 2027
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- rTMS
- Record updated
- 20 August 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for right-handed women with fibromyalgia. They will get rTMS, a magnetic brain stimulation, on the left or right side of the brain, with MRI brain scans.
- Age
- 18 to 65 years
- Sex
- Women only
- Disease stage
- Fibromyalgia diagnosed by a doctor using the American College of Rheumatology 2016 criteria. Pain for at least 3 months. Pain of at least 4/10 at enrolment. Fibromyalgia must be the main source of pain. Mild to moderate depression or anxiety is allowed.
- Earlier treatment
- Medicines for mood, pain and sleep must be at a steady dose for at least 4 weeks before joining and stay steady during the trial. People who ever had TMS, tDCS or electroconvulsive therapy (ECT) cannot join. Current use of tricyclic antidepressants or antipsychotic medicines is not allowed.
Main reasons for not taking part
- History of seizures or epilepsy, seizures in close family, stroke, brain injury, fainting, or brain surgery
- Schizophrenia, bipolar disorder, eating disorders or psychotic illness
- Metal implants, MRI-unsafe implants, fear of closed spaces, or other MRI or TMS safety problems
- Other main chronic pain, rheumatic or autoimmune disease, or serious unstable illness
- Pregnancy, substance misuse, or ongoing pain-related legal or disability claims
The registry criteria, word for word
Show all 33 criteriaShow less
Who can take part
- Female aged 18 to 65, right-handed, with no racial/ethnic restrictions
- A diagnosis of fibromyalgia by a qualified physician according to the American College of Rheumatology 2016 criteria
- Must have a history of fibromyalgia pain for a duration ≥ 3 months, as it is included in the diagnostic criteria
- Must have pain intensity equal or greater than 4/10 on the numerical rating scale (NRS) at enrollment
- Concurrent chronic overlapping pain conditions (except migraine with aura), depression, and anxiety will be allowed when mild to moderate (Less than 31 on Beck Depression Inventory or less than 36 on Beck Anxiety Inventory), except in cases with psychotic or manic features
- Concomitant medication (except tricyclics, antipsychotic medications, bupropion, methadone, theophylline) and their doses for mood, pain and sleep disorders must be steady at least 4 weeks before enrolment and must be kept at a steady dosage during the trial
- Must be able to read and speak English and be willing to read and understand instructions as well as questionnaires
- Must be in generally stable health
- Must sign an informed consent document after explanation of the study documenting that they understand the purpose of the study, procedures to be undertaken, possible benefits, potential risks, and are willing to participate
Who cannot take part
- Patients planning to change their medications during trial
- Participants who are currently receiving other alternative therapies during trial (e.g., physiotherapy, acupuncture)
- History of receiving TMS, transcranial direct current stimulation (tDCS), or electroconvulsive therapy (ECT)
- Fibromyalgia must be the primary complaint; hence patients cannot have another main source of pain (e.g., osteoarthritis). Patients will be asked to shade all the areas in which they experience pain on a body map. If they shade areas other than typical fibromyalgia pain, we will discuss any previous diagnosis, the intensity and chronicity of pain, and exclude them if chronic pain in any area outside the condition in to be studied is confirmed
- Involvement in litigation regarding their pain or having a disability claim or receiving workman compensation or seeking either because of their pain
- Intra-axial implants (e.g., spinal cord stimulators or pumps) that are MRI incompatible
- All exclusion criteria for MRI and TMS safety: any metallic implants, chips, or plates, cochlear implants, brain or skull abnormalities, aneurysm clips or coils, non-removable piercings, tattoos containing ferromagnetic ink, and claustrophobia
- Evidence of rheumatologic disorders, autoimmune diseases, taking immunosuppressive treatment, severe or unstable cardiac diseases
- Any history of hemorrhagic or thrombotic stroke
- History of schizophrenia, schizoaffective disorder, bipolar disorders, mania, hypomania, eating disorders, or any psychiatric illness with psychotic features (major depressive disorder, mild to moderate without psychosis, or anxiety disorders are not exclusion criteria)
- Current use of tricyclic antidepressants or any antipsychotic medications, given the risk of seizure incidence independent of TMS use in tricyclics is up to 0.4% or second-generation antipsychotics up to 1.2%
- Significant other medical disease such as unstable diabetes mellitus, congestive heart failure, coronary or peripheral vascular disease, chronic obstructive lung disease, sleep apnea, or malignancy. Stable diabetes mellitus, stable hypertension (meaning that these conditions are followed up on by a physician and they are getting treatment for it with clinical stability), or hyperlipidemia are not exclusion criteria
- History of traumatic brain injury
- History of epileptic disorders or family history of seizures in first degree relatives
- History of syncope
- History of tinnitus or hearing loss
- Current or history of substance misuse/dependence including alcohol at time of entry into the study
- History of COVID-19 infection with persistent neurologic symptoms
- Surgery within the past 3 months or history of any brain surgery
- Age outside the studied range (i.e., < 18, > 65)
- Inability to provide informed consent
- Pregnancy
- Participation into another research study
- In the judgment of the investigator, unable or unwilling to follow the protocol and instructions
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 65 years old?
Where in United States
- University of Rochester Medical CenterRochester, United StatesContact: Olivia Caraccio, BSTaking people
About the trial
What the trial wants to find out
The first goal of this study is to see how brain activity changes in people with fibromyalgia after they get a treatment called rTMS (repetitive transcranial magnetic stimulation). Researchers are looking at how the parts of the brain that control movement (called motor cortices) respond to this treatment.
Read full original descriptionShow less
The second goal is to find out if the changes in brain activity are different between the right and left sides of the brain, depending on which side gets the treatment.
The 2 groups in the trial
- right M1 rTMSExisting treatment, for comparison
Treatment: rTMS
- Left M1 rTMSExisting treatment, for comparison
Treatment: rTMS
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Investigating the Differential Effects of Repetitive Transcranial Magnetic Stimulation (rTMS) on Left and Right Motor Cortex in Fibromyalgia: A Prospective Randomized Trial With Functional Magnetic Resonance Imaging (MRI(
- Plain-language title
- Magnetic brain stimulation on the left or right side in fibromyalgiaGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Fit questions
- Built from NCT07260864, who can take part
- Record updated
- 20 August 2026